Divergences in antihypertensive therapy in special situations in nephrology

Detalhes bibliográficos
Autor(a) principal: Lemos,Marcelo Montebello
Data de Publicação: 2008
Outros Autores: Pedrosa,Alessandra Coelho, Tavares,Alze Pereira, Góes,Miguel Ângelo, Draibe,Sérgio Antônio, Sesso,Ricardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007
Resumo: CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.
id APM-1_12c5daa09ec92668a1a46871f0c10b89
oai_identifier_str oai:scielo:S1516-31802008000100007
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Divergences in antihypertensive therapy in special situations in nephrologyHypertensionAntihypertensive agentsKidney diseasesGuidelinesEvidence-based medicineCONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.Associação Paulista de Medicina - APM2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007Sao Paulo Medical Journal v.126 n.1 2008reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31802008000100007info:eu-repo/semantics/openAccessLemos,Marcelo MontebelloPedrosa,Alessandra CoelhoTavares,Alze PereiraGóes,Miguel ÂngeloDraibe,Sérgio AntônioSesso,Ricardoeng2008-04-14T00:00:00Zoai:scielo:S1516-31802008000100007Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2008-04-14T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Divergences in antihypertensive therapy in special situations in nephrology
title Divergences in antihypertensive therapy in special situations in nephrology
spellingShingle Divergences in antihypertensive therapy in special situations in nephrology
Lemos,Marcelo Montebello
Hypertension
Antihypertensive agents
Kidney diseases
Guidelines
Evidence-based medicine
title_short Divergences in antihypertensive therapy in special situations in nephrology
title_full Divergences in antihypertensive therapy in special situations in nephrology
title_fullStr Divergences in antihypertensive therapy in special situations in nephrology
title_full_unstemmed Divergences in antihypertensive therapy in special situations in nephrology
title_sort Divergences in antihypertensive therapy in special situations in nephrology
author Lemos,Marcelo Montebello
author_facet Lemos,Marcelo Montebello
Pedrosa,Alessandra Coelho
Tavares,Alze Pereira
Góes,Miguel Ângelo
Draibe,Sérgio Antônio
Sesso,Ricardo
author_role author
author2 Pedrosa,Alessandra Coelho
Tavares,Alze Pereira
Góes,Miguel Ângelo
Draibe,Sérgio Antônio
Sesso,Ricardo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Lemos,Marcelo Montebello
Pedrosa,Alessandra Coelho
Tavares,Alze Pereira
Góes,Miguel Ângelo
Draibe,Sérgio Antônio
Sesso,Ricardo
dc.subject.por.fl_str_mv Hypertension
Antihypertensive agents
Kidney diseases
Guidelines
Evidence-based medicine
topic Hypertension
Antihypertensive agents
Kidney diseases
Guidelines
Evidence-based medicine
description CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.
publishDate 2008
dc.date.none.fl_str_mv 2008-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31802008000100007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.126 n.1 2008
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209262099234816